X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (1468) 1468
humans (1449) 1449
ophthalmology (1005) 1005
male (920) 920
female (864) 864
middle aged (662) 662
adult (586) 586
aged (516) 516
conjunctival diseases - drug therapy (294) 294
treatment outcome (277) 277
animals (227) 227
administration, topical (199) 199
aged, 80 and over (197) 197
eye diseases (197) 197
conjunctival diseases - diagnosis (180) 180
surgery (177) 177
conjunctival neoplasms - drug therapy (174) 174
conjunctival diseases - pathology (172) 172
conjunctival diseases - etiology (171) 171
follow-up studies (168) 168
care and treatment (167) 167
conjunctiva (166) 166
adolescent (164) 164
abridged index medicus (158) 158
retrospective studies (158) 158
ophthalmic solutions (156) 156
prospective studies (156) 156
conjunctival diseases - chemically induced (147) 147
conjunctiva - pathology (144) 144
conjunctival neoplasms - pathology (144) 144
glaucoma (131) 131
eye (124) 124
diagnosis (122) 122
child (121) 121
ocular surface (119) 119
sense organs (115) 115
corneal diseases - drug therapy (112) 112
medicine & public health (104) 104
diagnosis, differential (100) 100
cornea (99) 99
therapy (98) 98
drug therapy, combination (93) 93
pharmacology & pharmacy (93) 93
conjunctiva - drug effects (91) 91
dry eye (90) 90
mitomycin - therapeutic use (88) 88
research (88) 88
risk factors (88) 88
biopsy (86) 86
young adult (86) 86
conjunctival (85) 85
genetic structures (83) 83
disease (82) 82
recurrence (81) 81
analysis (80) 80
conjunctival injection (80) 80
mitomycin - administration & dosage (80) 80
clinical neurology (79) 79
eye neoplasms - drug therapy (79) 79
corneal diseases - pathology (78) 78
drug therapy (77) 77
visual acuity (77) 77
double-blind method (75) 75
inflammation (75) 75
benzalkonium chloride (73) 73
health aspects (73) 73
tumors (73) 73
conjunctival diseases - complications (72) 72
management (72) 72
carcinoma in situ - drug therapy (71) 71
patients (69) 69
chemotherapy (67) 67
mitomycin-c (67) 67
combined modality therapy (64) 64
conjunctivitis (64) 64
corneal (64) 64
expression (64) 64
immunosuppressive agents - therapeutic use (64) 64
antibiotics, antineoplastic - therapeutic use (63) 63
prevalence (63) 63
glaucoma - drug therapy (62) 62
internal medicine (62) 62
open-angle glaucoma (62) 62
pterygium (62) 62
antineoplastic agents - therapeutic use (61) 61
in-vitro (61) 61
rabbits (60) 60
conjunctival diseases - surgery (59) 59
glucocorticoids - therapeutic use (59) 59
mitomycin (59) 59
melanoma (58) 58
intraocular pressure (57) 57
time factors (57) 57
anti-bacterial agents - therapeutic use (55) 55
cancer (55) 55
child, preschool (55) 55
immunology (55) 55
impression cytology (55) 55
mitomycin c (55) 55
intraocular pressure - drug effects (54) 54
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1679) 1679
French (23) 23
German (17) 17
Spanish (11) 11
Portuguese (6) 6
Polish (4) 4
Romanian (4) 4
Russian (4) 4
Chinese (2) 2
Czech (2) 2
Danish (1) 1
Dutch (1) 1
Italian (1) 1
Japanese (1) 1
Norwegian (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Ophthalmology, ISSN 0161-6420, 2010, Volume 117, Issue 2, pp. 356 - 365
Journal Article
Ophthalmology, ISSN 0161-6420, 2014, Volume 121, Issue 5, pp. 994 - 1000
Purpose Treatment for ocular surface squamous neoplasia (OSSN) has historically been surgery, but nonsurgical interventions are increasingly used. Treatment... 
AMERICAN-JOINT-COMMITTEE | CORNEAL | SOLID TUMORS | MITOMYCIN-C | OPHTHALMOLOGY | TERM-FOLLOW-UP | CANCER-CLASSIFICATION | CONJUNCTIVAL INTRAEPITHELIAL NEOPLASIA | HUMAN-PAPILLOMAVIRUS | TOPICAL INTERFERON-ALPHA-2B | CELL CARCINOMA | Recombinant Proteins - therapeutic use | Corneal Diseases - therapy | Conjunctival Neoplasms - drug therapy | Conjunctival Neoplasms - surgery | Carcinoma in Situ - drug therapy | Carcinoma, Squamous Cell - pathology | Humans | Middle Aged | Carcinoma, Squamous Cell - surgery | Male | Antineoplastic Agents - therapeutic use | Eye Neoplasms - therapy | Eye Neoplasms - surgery | Case-Control Studies | Ophthalmologic Surgical Procedures | Eye Neoplasms - drug therapy | Carcinoma in Situ - surgery | Aged, 80 and over | Ophthalmic Solutions | Adult | Female | Corneal Diseases - pathology | Postoperative Complications | Visual Acuity - physiology | Carcinoma in Situ - pathology | Risk Factors | Eye Neoplasms - pathology | Interferon-alpha - therapeutic use | Carcinoma, Squamous Cell - therapy | Corneal Diseases - drug therapy | Treatment Outcome | Neoplasm Recurrence, Local - diagnosis | Carcinoma in Situ - therapy | Conjunctival Neoplasms - therapy | Conjunctival Neoplasms - pathology | Corneal Diseases - surgery | Carcinoma, Squamous Cell - drug therapy | Aged | Neoplasm Staging | Cryotherapy | Index Medicus
Journal Article
Journal Article
Journal Article
Annals of Hematology, ISSN 0939-5555, 9/2012, Volume 91, Issue 9, pp. 1393 - 1401
In the present study, we evaluated the ophthalmologic outcomes of 24 patients who received chemotherapy and/or radiotherapy for the treatment of... 
Chemotherapy | Medicine & Public Health | Hematology | Oncology | Non-conjunctival MALT lymphoma | Ophthalmologic outcomes | Radiotherapy | 1ST-LINE TREATMENT | MALIGNANT-LYMPHOMA | MARGINAL ZONE | RADIATION-THERAPY | B-CELL LYMPHOMA | ORBIT | PROGNOSTIC-SIGNIFICANCE | CLINICAL BEHAVIOR | LYMPHOPROLIFERATIVE DISORDERS | HEMATOLOGY | TISSUE-TYPE | Cyclophosphamide - administration & dosage | Peripheral Nervous System Diseases - chemically induced | Cataract - chemically induced | Humans | Middle Aged | Retinal Diseases - chemically induced | Male | Lacrimal Apparatus Diseases - therapy | Radiotherapy - adverse effects | Chemoradiotherapy | Cyclophosphamide - adverse effects | Retinal Diseases - epidemiology | Eye Neoplasms - drug therapy | Radiotherapy, Adjuvant - adverse effects | Retinal Diseases - etiology | Aged, 80 and over | Ocular Hypertension - chemically induced | Vincristine - administration & dosage | Ocular Hypertension - epidemiology | Prednisone - adverse effects | Rituximab | Orbital Neoplasms - drug therapy | Combined Modality Therapy | Blepharitis - chemically induced | Vincristine - therapeutic use | Vincristine - adverse effects | Xerophthalmia - epidemiology | Antibodies, Monoclonal, Murine-Derived - adverse effects | Optic Nerve Diseases - epidemiology | Optic Nerve Diseases - etiology | Prednisone - therapeutic use | Antibodies, Monoclonal, Murine-Derived - therapeutic use | Eye Neoplasms - radiotherapy | Lymphoma, B-Cell, Marginal Zone - radiotherapy | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Blepharitis - epidemiology | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Lymphoma, B-Cell, Marginal Zone - therapy | Cataract - epidemiology | Eye Neoplasms - therapy | Cyclophosphamide - therapeutic use | Blepharitis - etiology | Orbital Neoplasms - therapy | Lacrimal Apparatus Diseases - drug therapy | Female | Xerophthalmia - etiology | Retrospective Studies | Orbital Neoplasms - radiotherapy | Doxorubicin - administration & dosage | Hematologic Diseases - chemically induced | Prednisone - administration & dosage | Optic Nerve Diseases - chemically induced | Cataract - etiology | Treatment Outcome | Lacrimal Apparatus Diseases - radiotherapy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Lymphoma, B-Cell, Marginal Zone - drug therapy | Aged | Ocular Hypertension - etiology | Xerophthalmia - chemically induced | Doxorubicin - adverse effects | Index Medicus
Journal Article
British Journal of Ophthalmology, ISSN 0007-1161, 08/2017, Volume 101, Issue 8, pp. 1094 - 1099
Journal Article
Pharmaceutical Research, ISSN 0724-8741, 06/2018, Volume 35, Issue 6, pp. 117 - 12
Journal Article
Ophthalmology, ISSN 0161-6420, 2016, Volume 123, Issue 7, pp. 1442 - 1448
Purpose To determine the efficacy of topical 5-fluorouracil 1% (5-FU) as a primary treatment of ocular surface squamous neoplasia (OSSN). Design Retrospective... 
<